Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Multiple Sclerosis

  Free Subscription


16.02.2026

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
2 Ann Neurol
1 BMC Neurol
1 Brain
6 J Neurol
1 J Neurol Neurosurg Psychiatry
2 J Neurol Sci
2 Mult Scler
2 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. TAKAI Y, Hametner S, Riedl C, Misu T, et al
    Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.
    Acta Neuropathol. 2026;151:13.
    PubMed         Abstract available


    AJNR Am J Neuroradiol

  2. DIEZ-CIRARDA M, Matias-Guiu JA, Ruiz-Ortiz M, Aladro Y, et al
    Ventral attention network connectivity differentiates radiologically isolated syndrome from multiple sclerosis: a longitudinal resting-state fMRI study.
    AJNR Am J Neuroradiol. 2026 Feb 9:ajnr.A9212. doi: 10.3174/ajnr.A9212.
    PubMed         Abstract available


    Ann Neurol

  3. CERONO G, Cree BAC, Hauser SL, Baranzini SE, et al
    Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".
    Ann Neurol. 2026;99:553.
    PubMed        

  4. LOREFICE L, Pellecchia MT
    Frailty across Neurological Diseases: Why Sex and Gender Matter.
    Ann Neurol. 2025 Nov 21. doi: 10.1002/ana.78110.
    PubMed         Abstract available


    BMC Neurol

  5. GHEZELHESARI EM, Tehrani MV, Nahayati M, Ebrahimipour H, et al
    A systematic review of consensus recommendations and guidelines on the management and care of women with multiple sclerosis through pre-pregnancy, pregnancy, and postpartum periods.
    BMC Neurol. 2026 Feb 14. doi: 10.1186/s12883-026-04635.
    PubMed        


    Brain

  6. ROLLOT F, Casey R, Kerbrat A, Edan G, et al
    Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.
    Brain. 2026 Feb 14:awag060. doi: 10.1093.
    PubMed         Abstract available


    J Neurol

  7. GUO J, Olsson T, Alfredsson L, Hedstrom AK, et al
    Patient-reported gradual worsening reveals progression beyond MS subtypes.
    J Neurol. 2026;273:117.
    PubMed         Abstract available

  8. GERNERT JA, Zausinger H, Diedrich L, Wicklein R, et al
    The potential of optical coherence tomography angiography in progressive multiple sclerosis.
    J Neurol. 2026;273:118.
    PubMed         Abstract available

  9. FREEDMAN DE, Oh J, Feinstein A
    Relationship status and the neurobehavioral symptoms of multiple sclerosis: a cross-sectional analysis.
    J Neurol. 2026;273:126.
    PubMed         Abstract available

  10. CORSTEN CEA, Geraedts VSA, Marques AM, Melief MJ, et al
    Serum neurofilament light chain and glial fibrillary acidic protein predicting multiple sclerosis after clinically isolated syndrome.
    J Neurol. 2026;273:128.
    PubMed         Abstract available

  11. VAN DEN BOOGAARD LJM, Bochman A, Drenthen GS, Knippenberg SAM, et al
    Longitudinal myelin MR imaging in patients with multiple sclerosis: a narrative review.
    J Neurol. 2026;273:136.
    PubMed         Abstract available

  12. QU B, Li S, Chen H, Zhang Y, et al
    Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI.
    J Neurol. 2026;273:139.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  13. MOSTERT J, Strijbis EM, D'Haeseleer M, Moral E, et al
    Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.
    J Neurol Neurosurg Psychiatry. 2026;97:229-238.
    PubMed         Abstract available


    J Neurol Sci

  14. NICOLELLA V, Terracciano D, Moccia M
    Authors response to Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis".
    J Neurol Sci. 2026;482:125819.
    PubMed        

  15. KARNBROCK L, Herwerth M, Bloemberg GV, Huber M, et al
    Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disorders.
    J Neurol Sci. 2026;482:125796.
    PubMed         Abstract available


    Mult Scler

  16. SHALASH A, Gams Massi D, Ben Sassi S, Tibar H, et al
    Availability and affordability of therapies and services of multiple sclerosis in Africa: A continent-wide survey.
    Mult Scler. 2026 Feb 12:13524585261417591. doi: 10.1177/13524585261417591.
    PubMed         Abstract available

  17. SANGHA KS, Jakubecz C, Maynard M, Hernandez RS, et al
    Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study.
    Mult Scler. 2026 Feb 9:13524585251412125. doi: 10.1177/13524585251412125.
    PubMed         Abstract available


    Neurology

  18. MILLER AE
    The 2024 McDonald Criteria for Diagnosis of Multiple Sclerosis: The Rubber Meets the Road.
    Neurology. 2026;106:e214688.
    PubMed        

  19. BROWNLEE WJ, Maccarrone D, Nistri R, Yam C, et al
    Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis.
    Neurology. 2026;106:e214688.
    PubMed         Abstract available


    PLoS One

  20. YANG B, Molton I, Humbert A, Baylor C, et al
    Environmental influences on community participation among people with multiple sclerosis: A mixed methods study.
    PLoS One. 2026;21:e0342678.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. CUI T, Wen Q, An Z, Kang J, et al
    Natalizumab exacerbates astrocytopathy in NMOSD via blockade of endothelial VCAM1-astrocytic integrin alpha4 interaction.
    Proc Natl Acad Sci U S A. 2026;123:e2520566123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum